Endocrinology and Rheumatology CME

Endocrinology and Rheumatology: The Most Useful Topics from Two Specialties
February 1-5, 2010 (8:00am-12:15pm) Location: Hyatt Regency Sarasota, Florida 20 AMA PRA Category 1 Credits™ 20 CME Credits - ACEP AAFP ACOG	Course #SEMLA-2420100201 Price: $645.00 - $795.00

by Thomas P. Olenginski, M.D., F.A.C.P. - Geisinger Medical Center, Geisinger Health System; Associate, Department of Rheumatology, Danville, PA and Frederick Sunderlin, M.D. - Jefferson Medical College, Thomas Jefferson University; Clinical Professor of Medicine; Associate, Department of Endocrinology, Geisinger Medical Center; Adjunct Professor of Medicine, Temple University School of Medicine; Clinical Professor, School of Graduate Studies, Lock Haven University, Lock Haven, PA.

Learning Objectives
What do our past participants have to say?
Refer a Colleague to Our Website

NARRATIVE DESCRIPTION: Following this course, the participant should be able to describe the epidemiology and etiologies of various commonly seen diseases within the specialties of Endocrinology and Rheumatology; develop a practical and cost effective approach to the use and ordering of laboratory and imaging tests to derive a reasonable differential or final diagnosis; identify the treatment options available and choose appropriate specialty referral or follow-up. This activity is expected to result in increased confidence in making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

When indicated in the specific objectives, emphasis will be on current guidelines and evidence-based medicine with a focus on diagnosis, treatment and when to refer. Since the specialties of Endocrinology and Rheumatology impact patient populations of all demographics, there is a need for providers to be up-to-date on common Endocrine and Rheumatologic diseases; therefore, this course was designed as a review and update for all practitioners at the level of a practicing physician.

Day 1 Osteoporosis 101: DXA & New WHO FRAX Model. Osteoporosis 102: Case Studies. Management of Type 1 Diabetes. Treatment Strategies in Type 2 Diabetes.

Day 2 Polycystic Ovary Syndrome. Adrenal Case Studies. Gout and Pseudogout: Acute Arthritis Visits to the Office/ER. Early Recognition and Treatment of Rheumatoid Arthritis (RA).

Day 3 Osteoarthritis: A Case-Based Approach. Doc, I Hurt All Over! The Fibromyalgia Syndrome. The Dyslipidemias: Evidence-Based Decision Making. Disorders of Calcium Metabolism.

Day 4 Thyroid Case Studies, Parts I & II. Rheumatology Pearls. Lupus: Approach to Diagnosis and Treatment.

Day 5 Polymyalgia Rheumatica and Giant Cell Arteritis. Recognition and Treatment of Spondyloarthropathies. Male Hypogonadism: Clinical Features. Pituitary Potpourri.

Home CME Calendar Quick Order E-Mail

Endocrinology and Rheumatology: The Most Useful Topics from Two Specialties
February 1-5, 2010
Location: Hyatt Regency Sarasota, Florida

SPECIFIC OBJECTIVES

Day 1

Osteoporosis 101: DXA & New WHO FRAX Model - Upon completion of this session, the participant should be able to:

1.	Utilize DXA and other clinical fracture risks in patient care.
2.	Recognize clinical indications for DXA.
3.	Apply the Revised National Osteoporosis Clinical Guidelines (Feb 2008).
4.	Utilize WHO 10 year Absolute Fracture Risk Model (WHO FRAX).
Osteoporosis 102: Case Studies - Upon completion of this session, the participant should be able to:
1.	List the current FDA approved treatments.
2.	Appreciate potential side effects of therapies.
3.	Respect the importance of Vertebral Fracture Assessment (VFA) and implications of fracture.
4.	Employ the WHO FRAX Absolute Fracture Risk Tool and realize its limitations.
Management of Type 1 Diabetes - Upon completion of this session, the participant should be able to:
1.	Review current diagnostic criteria for the diagnosis of diabetes.
2.	Discuss new insulin regimens for intensive glucose control.
3.	Discuss the benefits of tight control of glycemia.
Treatment Strategies in Type 2 Diabetes - Upon completion of this session, the participant should be able to:
1.	Describe new pharmacologic agents available for glucose control.
2.	Apply concepts of pathophysiology to the selection of pharmacotherapy for Type 2 Diabetes.
3.	Discuss the risks/benefits of tight glycemic control.

Day 2

Polycystic Ovary Syndrome - Upon completion of this session, the participant should be able to:

1.	Review current concepts in risk factors and pathophysiology.
2.	Develop a simple laboratory screening process for diagnosis.
3.	Apply our understanding of pathophysiology to design a treatment strategy.
Adrenal Case Studies - Upon completion of this session, the participant should be able to:
1.	Discuss the evaluation of the incidental adrenal mass.
2.	Diagnose and treat adrenal insufficiency.
3.	Manage patients with excessive adrenal steroid levels.
Gout and Pseudogout: Acute Arthritis Visits to the Office/ER - Upon completion of this session, the participant should be able to:
1.	Define the common presenting symptoms of crystalline arthritis.
2.	Differentiate gout or pseudogout from septic arthritis.
3.	Apply diagnostic arthrocentesis and crystal analysis in the evaluation.
4.	Discriminate and apply the treatment principles in primary care.
Early Recognition and Treatment of Rheumatoid Arthritis (RA) - Upon completion of this session, the participant should be able to:
1.	Recognize the early clinical manifestations of RA.
2.	Utilize newer diagnostic serology testing.
3.	Distinguish DMARD versus Biologic therapies.
4.	Utilize the evidence to recall the benefits of early Rheumatology referral.

Day 3

Osteoarthritis: A Case-Based Approach - Upon completion of this session, the participant should be able to:

1.	Utilize case studies to recognize the clinical signs and symptoms.
2.	Appreciate diagnostic x-ray features.
3.	Apply case studies to initiate treatment strategies.
4.	Appreciate what treatments may be more likely to cause side effects or serious adverse reactions.
Doc, I Hurt All Over! The Fibromyalgia Syndrome - Upon completion of this session, the participant should be able to:
1.	Recognize the common and non-specific symptoms of this malady.
2.	Differentiate FMS from other rheumatic syndromes.
3.	Initiate symptom-based treatment in FMS.
4.	Appreciate new pathophysiologic insights that affect treatment decisions.
The Dyslipidemias: Evidence-Based Decision Making - Upon completion of this session, the participant should be able to:
1.	Discuss landmark outcomes studies in reducing cardiovascular risk.
2.	Review the available lipid lowering therapies.
3.	Apply evidence-based protocols to at-risk patients.
Disorders of Calcium Metabolism - Upon completion of this session, the participant should be able to:
1.	Discuss the differential diagnosis of hypercalcemia.
2.	Apply a cost effective workup to elevated calcium states.
3.	Evaluate hypocalcemic disorders using common laboratory studies.

Day 4

Thyroid Case Studies, Parts I & II - Upon completion of this session, the participant should be able to:

1.	Review the etiologies and pathogenesis of hyper and hypothyroidism.
2.	Apply cost effective principles in the laboratory evaluation of thyroid conditions.
3.	Design effective treatment protocols for various thyroid conditions.
Rheumatology Pearls - Upon completion of this session, the participant should be able to:
1.	Apply relevant Rheumatology take-home points to daily primary care.
2.	Appreciate clinical signs, findings, and x-ray features to assist in earlier diagnosis and treatment.
Lupus: Approach to Diagnosis and Treatment - Upon completion of this session, the participant should be able to:
1.	Recall the common presenting signs and symptoms.
2.	Appreciate the evidence behind serologic testing methods.
3.	Recognize clinical ‘subgroups’ of lupus.
4.	Initiate evidence-based treatment strategies in SLE.

Day 5

Polymyalgia Rheumatica and Giant Cell Arteritis - Upon completion of this session, the participant should be able to:

1.	Recognize the clinical signs and symptoms of PMR and GCA.
2.	Employ evidence-based laboratory and other diagnostic testing methods.
3.	Recall the clinical indications for temporal artery biopsy.
4.	Initiate early therapy and appraise possible treatment complications.
Recognition and Treatment of Spondyloarthropathies - Upon completion of this session, the participant should be able to:
1.	Recognize the unique clinical signs and symptoms of this arthritis family.
2.	Utilize NSAID and DMARD therapies.
3.	Appreciate diagnostic x-ray features.
4.	Apply consensus guidelines for use of Biologic Therapies.
Male Hypogonadism: Clinical Features - Upon completion of this session, the participant should be able to:
1.	Discuss the concept of “male menopause”.
2.	Design a cost-effective strategy to investigate causes of male hypogonadism.
3.	Treat various endocrine conditions arising in men.
Pituitary Potpourri - Upon completion of this session, using 5 minute cases studies, the participant should be able to:
1.	Provide a differential diagnosis based on clinical features.
2.	Formulate a laboratory workup using a “best test” approach.
3.	Discuss treatment options.

Home CME Calendar Quick Order E-Mail

Copyright © 1997 - 2010 by AMS, Inc. All rights reserved. AMS, Inc. is an ACCME Accredited Continuing Medical Education Company. Information on this page is subject to change without notice.

Site Terms | About AMS
URL: http://www.ams4cme.com/www/LiveSeminars/SEMLA-2420100201.aspx
E-Mail: mail@ams4cme.com
Updated: December 12, 2009
CME / Audio CME / CME Video / CME Live Seminars